Market Tracker

02/24 5:16pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

87.51
Delayed Data
As of Feb 24
 -1.78 / -1.99%
Today’s Change
72.96
Today|||52-Week Range
102.49
+5.64%
Year-to-Date

Today’s Trading

Previous close89.29
Today’s open87.99
Day’s range85.88 - 88.82
Volume2,390,386
Average volume (3 months)1,225,020
Market cap$15.1B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+73.95%
Earnings growth (next 5 years)+77.50%
Revenue growth (last year)+27.88%
P/E ratioNM
Price/Sales12.33
Price/Book5.46

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.36+0.43%
TSROTESARO Inc+0.96+0.52%
SGENSeattle Genetics Inc-0.34-0.54%
VRTXVertex Pharmaceutica...+0.34+0.40%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts